News

Video

Changing Landscape of Endometrial Cancer: Incidence and Classification

Author(s):

Ritu Salani, MD,Bhavana Pothuri, MD

Dive into the evolving landscape of endometrial cancer, including rising incidence, classification, racial disparities, and emerging modalities, as discussed by experts Ritu Salani, MD, MBA, and Bhavana Pothuri, MD.

Newsletter

Stay up to date on the most recent and practice-changing oncology data

Subscribe Now!
Related Videos
Shannon N. Westin, MD, MPH, FACOG, director, Early Drug Development, clinical medical director, professor, Department of Gynecologic Oncology and Reproductive Medicine, Division of Surgery, codirector, Ovarian Cancer Moonshot Program, The University of Texas MD Anderson Cancer Center
Jordyn Silverstein, MD
Rachel N. Grisham, MD
Toon Van Gorp, MD, PhD
2 experts in this video
2 experts in this video
2 experts in this video
2 experts in this video
Related Content
Selinexor in Endometrial Cancer
March 17th 2025

Maintenance Selinexor Extends PFS in TP53 Wild-Type Endometrial Cancer

Bradley J. Monk, MD, FACOG, FACS; Paolo Tarantino, MD
January 11th 2024

Monk and Tarantino Describe the Investigation of B7-H4 Vedotin–Directed ADCs in Gynecologic and Breast Cancers

Rina-S in Platinum-Resistant Ovarian Cancer | Image Credit: © LASZLO - stock.adobe.com
March 17th 2025

Real-World Analysis Confirms Efficacy/Safety of Dostarlimab Plus Chemotherapy in Advanced Endometrial Cancer

Diane M. Simeone, MD; Marwan G. Fakih, MD
December 18th 2023

Simeone and Fakih Detail Research Objectives With A2B530 in CEA-Expressing Solid Tumors

Endometrial Cancer | Image credit: © Crystal light - stock.adobe.com
March 16th 2025

Puxitatug Samrotecan Demonstrates Efficacy, Manageable Safety in Advanced/Metastatic Endometrial Cancer

Durvalumab plus BVAC-C for Cervical Cancer
March 16th 2025

BVAC-C Vaccine Therapy Plus Durvalumab Elicits Responses in Recurrent HPV+ Cervical Cancer